Focus on the Beta Cells
Anne L. Peters, MD, CDE: Hi. I am Dr. Anne Peters, Director of the Clinical Diabetes Programs at the University of Southern California. I am here at the American Diabetes Association (ADA) meeting in Chicago, Illinois. With me is Dr. Raghu Mirmira, Eli Lilly Professor, Director of Diabetes Research and Director of the Indiana University Medical Science Training Program at the Indiana University School of Medicine.
What have you found interesting at this meeting? You were involved in organizing the meeting; could you tell us about that?
Raghu G. Mirmira, MD, PhD: I was asked to help organize these meetings primarily to put a focus on areas that I felt were important in the future of diabetes research and therapy. Our focus this year has been on the function of the insulin-producing cells (beta cells), and we have organized several symposia that focus on different molecular pathways in the beta cell that could be targeted by drugs, either to enhance insulin release or to prevent the beta cell from dying off, which is an issue in all forms of diabetes. We have put those topics together with a series of "Meet the Expert" sessions and a variety of poster sessions.
Medscape Diabetes © 2013 WebMD, LLC
Cite this: Beta Cells: 'Where It All Begins' - Medscape - Jun 26, 2013.
Does COVID-19 Raise the Risk for Diabetes?
Does COVID-19 Induce Type 1 Diabetes in Kids? Jury Still Out
Urination Problems After Procedure in a Man Treated for BPH
COMMENTARY
Beta Cells: 'Where It All Begins'
Anne L. Peters, MD, CDE; Raghu G. Mirmira, MD, PhD
DisclosuresJune 26, 2013
Focus on the Beta Cells
Anne L. Peters, MD, CDE: Hi. I am Dr. Anne Peters, Director of the Clinical Diabetes Programs at the University of Southern California. I am here at the American Diabetes Association (ADA) meeting in Chicago, Illinois. With me is Dr. Raghu Mirmira, Eli Lilly Professor, Director of Diabetes Research and Director of the Indiana University Medical Science Training Program at the Indiana University School of Medicine.
What have you found interesting at this meeting? You were involved in organizing the meeting; could you tell us about that?
Raghu G. Mirmira, MD, PhD: I was asked to help organize these meetings primarily to put a focus on areas that I felt were important in the future of diabetes research and therapy. Our focus this year has been on the function of the insulin-producing cells (beta cells), and we have organized several symposia that focus on different molecular pathways in the beta cell that could be targeted by drugs, either to enhance insulin release or to prevent the beta cell from dying off, which is an issue in all forms of diabetes. We have put those topics together with a series of "Meet the Expert" sessions and a variety of poster sessions.
Medscape Diabetes © 2013 WebMD, LLC
Cite this: Beta Cells: 'Where It All Begins' - Medscape - Jun 26, 2013.
Tables
References
Authors and Disclosures
Authors and Disclosures
Interviewer
Anne L. Peters, MD, CDE
Professor of Clinical Medicine; Director, Clinical Diabetes Programs, Keck School of Medicine, University of Southern California, Los Angeles, California
Disclosure: Anne L. Peters, MD, CDE, has disclosed the following financial relationships:
Served as director, officer, partner, employee, advisor, consultant, or trustee for: (current consultant): Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk.
Served as a speaker or member of a speakers bureau for: (current speakers bureau member): Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk; Takeda Pharmaceuticals North America, Inc.
Served as a consultant or ad hoc speaker/consultant for: AstraZeneca Pharmaceuticals LP; Abbott Laboratories; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Dexcom; Medtronic MiniMed, Inc.; Merck & Co., Inc.; Roche; sanofi-aventis
Interviewee
Raghu G. Mirmira, MD, PhD
Lilly Foundation Professor in Pediatric Diabetes, Department of Pediatrics; Director, Diabetes Research; Director, Indiana University Medical Scientist Training Program, Indiana University School of Medicine, Indianapolis, Indiana
Disclosure: Raghu G. Mirmira, MD, PhD, has disclosed the following relevant financial relationships:
Served as a speaker or member of a speakers bureau for: Merck & Co., Inc.
Received a research grant from: Merck & Co., Inc.